Monosodium Glutamate vs Butylated Hydroxyanisole: which is worse?
Quick answer: Butylated Hydroxyanisole carries the heavier risk profile. Monosodium Glutamate is — in the EU and — in the US; Butylated Hydroxyanisole is — in the EU and — in the US.
| Property | Monosodium Glutamate | Butylated Hydroxyanisole |
|---|---|---|
| EU status | — | — |
| US status | — | — |
| Risk level | — | — |
| Banned in | — | Japan (banned for use in foods containing fats and oils) |
| Restricted in | Australia/New Zealand (required labeling), European Union (required declaration as 'flavor enhancer MSG (E621)') | European Union (restricted; banned in baby food), United Kingdom, Australia/New Zealand (ADI-based limits) |
| Category | additive | additive |
| Where it hides | — | — |
What is Monosodium Glutamate?
Monosodium glutamate (MSG) is the sodium salt of glutamic acid, a naturally occurring non-essential amino acid found in many proteins. It is used as a flavor enhancer to intensify umami (savory) taste. MSG was first isolated from seaweed in 1908 by Japanese chemist Kikunae Ikeda and has been used commercially since then.
What is Butylated Hydroxyanisole?
Butylated hydroxyanisole (BHA) is a synthetic phenolic antioxidant preservative derived from petroleum. It is a mixture of two isomeric compounds (2-BHA and 3-BHA). BHA prevents fats and oils from oxidizing (going rancid), extending shelf life. Its chemical formula is C11H16O2.
Documented risks
Monosodium Glutamate: MSG safety has been one of the most extensively debated food additive questions in the past 50 years. The 'Chinese Restaurant Syndrome' — a cluster of symptoms (headache, flushing, sweating, chest tightness) reported after eating Chinese food — was attributed to MSG in a 1968 letter in the New England Journal of Medicine. This set off decades of controversy. Multiple rigorous double-blind, placebo-controlled trials have failed to consistently demonstrate that MSG at doses present in food causes these symptoms when participants do not know whether they received MSG or a placebo. A comprehensive 1993 review by the FDA-commissioned Federation of American Societies for Experimental Biology (FASEB) found that while some sensitive individuals may experience symptoms at high doses (>3g of pure MSG on an empty stomach), the doses in typical food servings do not consistently produce symptoms in double-blind conditions. The FDA classifies MSG as GRAS (generally recognized as safe). EFSA's 2017 re-evaluation set an ADI of 30 mg/kg body weight per day, acknowledging that very high doses could affect neurological function but concluding typical dietary exposure is safe. Critics including Dr. Russell Blaylock and advocacy groups have argued that MSG is an 'excitotoxin' — a compound that overstimulates glutamate receptors in the brain and could cause neuronal damage. While glutamate is indeed a neurotransmitter and high-dose glutamate can cause neurotoxicity in animal models, the blood-brain barrier and normal metabolic regulation are generally considered sufficient to prevent dietary MSG from affecting brain glutamate levels. A 2018 EFSA re-evaluation noted that combined exposure to glutamates from all sources (including naturally occurring glutamate in protein-rich foods and other added glutamates E621-E625) could approach the new lower ADI in high consumers — a concern particularly for children with high processed food intake.
Butylated Hydroxyanisole: BHA is classified by the International Agency for Research on Cancer (IARC) as Group 2B (possible human carcinogen) based on studies showing it causes papillomas and squamous cell carcinomas of the forestomach in rats, hamsters, and mice at high doses. A 1983 NTP bioassay confirmed these findings. The National Toxicology Program lists BHA as 'reasonably anticipated to be a human carcinogen' in its Report on Carcinogens. The forestomach is an anatomical structure found in rodents but not humans, creating some uncertainty about direct extrapolation. EFSA's 2012 re-evaluation (EFSA Journal 2012;10(10):2588) concluded that BHA may have endocrine-disrupting potential based on animal data showing interactions with estrogen receptors and androgenic hormone pathways. EFSA found the ADI of 1 mg/kg body weight but noted concerns about endocrine effects. Japan banned BHA for use in foods containing fats and oils, consistent with its generally precautionary approach to synthetic food preservatives. In cosmetics, the EU Scientific Committee on Consumer Safety (SCCS) has assessed BHA and found potential endocrine-disrupting effects at dermal exposure levels. EWG rates BHA as high-concern in Skin Deep cosmetics database. The antioxidant paradox applies: while BHA prevents lipid oxidation in foods, it may paradoxically act as a pro-oxidant in certain biological contexts at certain doses.
Scan a barcode and we'll flag both Monosodium Glutamate and Butylated Hydroxyanisole (plus 200+ other ingredients banned overseas).
Scan free →